Incyte makes bid to join the checkpoint inhibitor clubIncyte has filed its PD-1 inhibitor retifanlimab with the FDA, seeking approval to treat a form of anal Share XIncyte makes bid to join the checkpoint inhibitor clubhttps://pharmaphorum.com/news/incyte-makes-bid-to-join-the-checkpoint-inhibitor-club/
